Status: Recruiting
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
The purpose of this study is twofold. First, is to determine whether vancomycin is effective in the early treatment of Biliary Atresia (BA) and Primary Sclerosing Cholangitis (PSC), and if so, by what mechanism. Secondly, to characterize human intestinal microbial communities and their interactions with the host.
Participants needed: 200
Trial details
Phase: Phase 1Age: 2-40Biological sex: AllType: InterventionalSponsor: Sacramento Pediatric GastroenterologyUpdated: Nov 15, 2016Locations: 1
Eligibility criteria
Persons who have primary sclerosing cholangitis, biliary atresia, a chronic inte... [+1]
Patients that have taken antibiotics and/or immunomodulators within the last 3 m... [+1]